| The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags H Brentani, OL Caballero, AA Camargo, AM da Silva, WA da Silva Jr, ... Proceedings of the National Academy of Sciences 100 (23), 13418-13423, 2003 | 142 | 2003 |
| Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients CM Lopes-Ramos, A Habr-Gama, BS Quevedo, NM Felício, F Bettoni, ... BMC medical genomics 7 (1), 68, 2014 | 85 | 2014 |
| Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for … E Donnard, PF Asprino, BR Correa, F Bettoni, FC Koyama, FCP Navarro, ... Oncotarget 5 (19), 9199, 2014 | 72 | 2014 |
| The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation P Carpinetti, E Donnard, F Bettoni, P Asprino, F Koyama, A Rozanski, ... Oncotarget 6 (35), 38360-38371, 2015 | 71 | 2015 |
| Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC FH Knebel, F Bettoni, AK Shimada, M Cruz, JV Alessi, MV Negrão, ... Lung Cancer 108, 238-241, 2017 | 69 | 2017 |
| Nineteen additional unpredicted transcripts from human chromosome 21 A Reymond, AA Camargo, S Deutsch, BJ Stevenson, RB Parmigiani, ... Genomics 79 (6), 824-832, 2002 | 67 | 2002 |
| Intratumoral Genetic Heterogeneity in Rectal Cancer: Are Single Biopsies representative of the entirety of the tumor? F Bettoni, C Masotti, A Habr-Gama, BR Correa, J Gama-Rodrigues, ... Annals of Surgery 265 (1), e4-e6, 2017 | 62 | 2017 |
| Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in … C Lopes-Ramos, FC Koyama, A Habr-Gama, ACM Salim, F Bettoni, ... Cancer genetics 208 (6), 319-326, 2015 | 57 | 2015 |
| Allele‐specific transcript isoforms in human V Nembaware, KH Wolfe, F Bettoni, J Kelso, C Seoighe FEBS letters 577 (1-2), 233-238, 2004 | 52 | 2004 |
| Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients RB Parmigiani, F Bettoni, MD Vibranovski, MH Lopes, WK Martins, ... Proceedings of the National Academy of Sciences 103 (48), 18066-18071, 2006 | 47 | 2006 |
| A transcript finishing initiative for closing gaps in the human transcriptome MC Sogayar, AA Camargo, ... Genome research 14 (7), 1413-1423, 2004 | 32 | 2004 |
| Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis F Bettoni, F Camargo Filho, DM Grosso, PAF Galante, RB Parmigiani, ... Genomics 94 (3), 153-160, 2009 | 31 | 2009 |
| The effects of neoadjuvant chemoradiation in locally advanced rectal cancer—the impact in intratumoral heterogeneity F Bettoni, C Masotti, BR Corrêa, E Donnard, FF Dos Santos, ... Frontiers in oncology 9, 974, 2019 | 27 | 2019 |
| Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient MFSA Ribeiro, FH Knebel, F Bettoni, R Saddi, KP Sacardo, FSNA Canedo, ... NPJ Precision Oncology 5 (1), 5, 2021 | 26 | 2021 |
| A straightforward assay to evaluate DNA integrity and optimize next-generation sequencing for clinical diagnosis in oncology F Bettoni, FC Koyama, P de Avelar Carpinetti, PAF Galante, AA Camargo, ... Experimental and molecular pathology 103 (3), 294-299, 2017 | 22 | 2017 |
| Antibodies against the cancer‐testis antigen CTSP‐1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical‐recurrence RB Parmigiani, F Bettoni, DM Grosso, A Lopes, IW Cunha, FA Soares, ... International Journal of Cancer 122 (10), 2385-2390, 2008 | 20 | 2008 |
| Circulating tumor DNA detection in the management of anti-EGFR therapy for advanced colorectal cancer FH Knebel, F Bettoni, LG da Fonseca, AA Camargo, J Sabbaga, ... Frontiers in Oncology 9, 170, 2019 | 17 | 2019 |
| Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis RAS Barreiro, J Sabbaga, BM Rossi, MIW Achatz, F Bettoni, AA Camargo, ... The Journal of Pathology 256 (2), 214-222, 2022 | 14 | 2022 |
| Choice of 16S ribosomal RNA primers impacts male urinary microbiota profiling V Heidrich, LT Inoue, PF Asprino, F Bettoni, ACH Mariotti, DA Bastos, ... Frontiers in Cellular and Infection Microbiology 12, 862338, 2022 | 10 | 2022 |
| Genomic biomarkers and underlying mechanism of benefit from BCG immunotherapy in non-muscle invasive bladder cancer DA Bastos, RL Mattedi, R Barreiro, FF dos Santos, V Buzatto, C Masotti, ... Bladder Cancer 6 (2), 171-186, 2020 | 8 | 2020 |
